1. Home
  2. BIAF vs HIHO Comparison

BIAF vs HIHO Comparison

Compare BIAF & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • HIHO
  • Stock Information
  • Founded
  • BIAF 2014
  • HIHO 1990
  • Country
  • BIAF United States
  • HIHO Hong Kong
  • Employees
  • BIAF N/A
  • HIHO N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HIHO Industrial Machinery/Components
  • Sector
  • BIAF Health Care
  • HIHO Industrials
  • Exchange
  • BIAF Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • BIAF 7.1M
  • HIHO 7.6M
  • IPO Year
  • BIAF 2022
  • HIHO 1996
  • Fundamental
  • Price
  • BIAF $0.24
  • HIHO $1.63
  • Analyst Decision
  • BIAF Hold
  • HIHO
  • Analyst Count
  • BIAF 1
  • HIHO 0
  • Target Price
  • BIAF N/A
  • HIHO N/A
  • AVG Volume (30 Days)
  • BIAF 468.1K
  • HIHO 12.6K
  • Earning Date
  • BIAF 08-14-2025
  • HIHO 10-09-2025
  • Dividend Yield
  • BIAF N/A
  • HIHO 7.34%
  • EPS Growth
  • BIAF N/A
  • HIHO N/A
  • EPS
  • BIAF N/A
  • HIHO 0.02
  • Revenue
  • BIAF $7,681,059.00
  • HIHO $7,412,000.00
  • Revenue This Year
  • BIAF N/A
  • HIHO N/A
  • Revenue Next Year
  • BIAF $20.00
  • HIHO N/A
  • P/E Ratio
  • BIAF N/A
  • HIHO $81.73
  • Revenue Growth
  • BIAF 4.99
  • HIHO 17.26
  • 52 Week Low
  • BIAF $0.16
  • HIHO $1.40
  • 52 Week High
  • BIAF $2.26
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 39.54
  • HIHO 46.31
  • Support Level
  • BIAF $0.24
  • HIHO $1.66
  • Resistance Level
  • BIAF $0.26
  • HIHO $1.70
  • Average True Range (ATR)
  • BIAF 0.02
  • HIHO 0.06
  • MACD
  • BIAF 0.00
  • HIHO -0.00
  • Stochastic Oscillator
  • BIAF 17.02
  • HIHO 12.30

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: